View Single Post
Old 02-20-2012, 11:13 AM   #2
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: new trial featuring anti-her2 vaccine plus lapatinib (phase I published)

Quote:
The median time to progression was 55 days, with the majority of patients progressing prior to induction of peak anti-HER2 immune responses
Looks like another situation where the typical RECIST criteria might be jumping the gun.
Rich66 is offline   Reply With Quote